Skip to main content

Table 6 Comparison of laboratory parameters and cognitive scale scores between MS patients distributed according to treatment type

From: Clinical predictors to cognitive impairment in multiple sclerosis patients

  Treatment type  
  Immuno-modulator Immunosuppressive P value
ACE attention
 Mean ± SD 17.0 ± 1.2 15.9 ± 1.3 0.009*
ACE memory
 Mean ± SD 20.9 ± 2.2 18.1 ± 1.3 < 0.001*
ACE language
 Mean ± SD 23.3 ± 1.7 20.0 ± 1.6 < 0.001*
ACE fluency
 Mean ± SD 10.3 ± 1.6 9.9 ± 1.9 0.521
ACE visuospatial
 Mean ± SD 15.4 ± 1.1 15.3 ± 1.2 0.727
ACE total
 Mean ± SD 86.8 ± 5.7 79.3 ± 2.0 < 0.001*
PASAT 3
 Mean ± SD 23.6 ± 8.6 16.4 ± 7.7 0.011*
Trail making type B
 Mean ± SD 176.4 ± 67.1 212.9 ± 79.0 0.127
  1. *Statistically significant
  2. ACE Addenbrooke’s cognitive examination III, PASAT 3 Paced auditory serial addition test, SD standard deviation
  3. P value is significant if ≤ 0.050